BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol. 2012;47:1177-1185. [PMID: 22766747 DOI: 10.1007/s00535-012-0627-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Raahave D, Jensen AK. Increased colon transit time and faecal load in irritable bowel syndrome. World J Gastrointest Pharmacol Ther 2021;12:13-20. [PMID: 33564493 DOI: 10.4292/wjgpt.v12.i1.13] [Reference Citation Analysis]
2 Cai T, Wang X, Li B, Xiong F, Wu H, Yang X. Deciphering the synergistic network regulation of active components from SiNiSan against irritable bowel syndrome via a comprehensive strategy: Combined effects of synephrine, paeoniflorin and naringin. Phytomedicine 2021;86:153527. [PMID: 33845366 DOI: 10.1016/j.phymed.2021.153527] [Reference Citation Analysis]
3 Stasi C, Bellini M, Gambaccini D, Duranti E, de Bortoli N, Fani B, Albano E, Russo S, Sudano I, Laffi G, Taddei S, Marchi S, Bruno RM. Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study. J Neurogastroenterol Motil 2017;23:428-34. [PMID: 28460516 DOI: 10.5056/jnm16155] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
4 Stasi C, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Grosso M, Duranti E, Metelli MR, Gambaccini D, Bianchi L. Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis. 2013;28:1203-1208. [PMID: 23377858 DOI: 10.1007/s00384-013-1646-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
5 Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome - from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:1-9. [PMID: 29358788 DOI: 10.5507/bp.2017.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Liu Q, Wang EM, Yan XJ, Chen SL. Autonomic functioning in irritable bowel syndrome measured by heart rate variability: a meta-analysis. J Dig Dis. 2013;14:638-646. [PMID: 23927739 DOI: 10.1111/1751-2980.12092] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
7 Goo YA, Cain K, Jarrett M, Smith L, Voss J, Tolentino E, Tsuji J, Tsai YS, Panchaud A, Goodlett DR, Shulman RJ, Heitkemper M. Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups. J Proteome Res 2012;11:5650-62. [PMID: 22998556 DOI: 10.1021/pr3004437] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
8 Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, Roger M, Tamouza R, Leboyer M, Boyer L. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264:651-660. [PMID: 24705634 DOI: 10.1007/s00406-014-0502-z] [Cited by in Crossref: 218] [Cited by in F6Publishing: 174] [Article Influence: 31.1] [Reference Citation Analysis]
9 Devanarayana NM, Rajindrajith S. Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World J Gastroenterol. 2018;24:2211-2235. [PMID: 29881232 DOI: 10.3748/wjg.v24.i21.2211] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
10 Shulman RJ, Jarrett ME, Cain KC, Broussard EK, Heitkemper MM. Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome. J Gastroenterol 2014;49:1467-76. [PMID: 24435814 DOI: 10.1007/s00535-013-0919-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
11 Fuentes IM, Christianson JA. The Influence of Early Life Experience on Visceral Pain. Front Syst Neurosci 2018;12:2. [PMID: 29434541 DOI: 10.3389/fnsys.2018.00002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 Lee YT, Hu LY, Shen CC, Huang MW, Tsai SJ, Yang AC, Hu CK, Perng CL, Huang YS, Hung JH. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. PLoS One. 2015;10:e0133283. [PMID: 26222511 DOI: 10.1371/journal.pone.0133283] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
13 Lin WT, Liao YJ, Peng YC, Chang CH, Lin CH, Yeh HZ, Chang CS. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World J Gastroenterol 2017;23:3513-21. [PMID: 28596687 DOI: 10.3748/wjg.v23.i19.3513] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Yang M, Fukui H, Eda H, Xu X, Kitayama Y, Hara K, Kodani M, Tomita T, Oshima T, Watari J. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol. 2017;312:G367-G373. [PMID: 28154011 DOI: 10.1152/ajpgi.00232.2016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
15 O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015;277:32-48. [PMID: 25078296 DOI: 10.1016/j.bbr.2014.07.027] [Cited by in Crossref: 747] [Cited by in F6Publishing: 599] [Article Influence: 106.7] [Reference Citation Analysis]
16 Chira A, Braicu C, Budisan L, Ioan Chira R, Berindan-Neagoe I, Lucian Dumitrascu D. Monocyte chemotactic protein-1 and nitrotyrosine in irritable bowel syndrome. Exp Ther Med 2020;20:24-30. [PMID: 32508988 DOI: 10.3892/etm.2020.8665] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Clark A, Mach N. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr 2016;13:43. [PMID: 27924137 DOI: 10.1186/s12970-016-0155-6] [Cited by in Crossref: 139] [Cited by in F6Publishing: 109] [Article Influence: 27.8] [Reference Citation Analysis]
18 Azpiroz F, Feinle-Bisset C, Grundy D, Tack J. Gastric sensitivity and reflexes: basic mechanisms underlying clinical problems. J Gastroenterol. 2014;49:206-218. [PMID: 24306100 DOI: 10.1007/s00535-013-0917-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
19 Gareau MG. Microbiota-gut-brain axis and cognitive function. Adv Exp Med Biol 2014;817:357-71. [PMID: 24997042 DOI: 10.1007/978-1-4939-0897-4_16] [Cited by in Crossref: 85] [Cited by in F6Publishing: 63] [Article Influence: 12.1] [Reference Citation Analysis]
20 Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, Yasui-furukori N. Irritable bowel syndrome and quality of life in a community-dwelling population in Japan. Int J Psychiatry Med 2018;53:159-70. [DOI: 10.1177/0091217417749791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 De Palma G, Collins SM, Bercik P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes. 2014;5:419-429. [PMID: 24921926 DOI: 10.4161/gmic.29417] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
22 Li TX, Hu L, Zhang MM, Sun J, Qiu Y, Rui JQ, Yang XH. A sensitive UPLC-MS/MS method for simultaneous determination of eleven bioactive components of Tong-Xie-Yao-Fang decoction in rat biological matrices. J Chromatogr B Analyt Technol Biomed Life Sci 2014;944:90-100. [PMID: 24295908 DOI: 10.1016/j.jchromb.2013.11.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
23 Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126-14131. [PMID: 25339801 DOI: 10.3748/wjg.v20.i39.14126] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 78] [Article Influence: 15.8] [Reference Citation Analysis]
24 Stasi C, Bellini M, Bassotti G, Blandizzi C, Milani S. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome. Tech Coloproctol. 2014;18:613-621. [PMID: 24425100 DOI: 10.1007/s10151-013-1106-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 8.3] [Reference Citation Analysis]
25 Pescatori M, Podzemny V, Pescatori LC, Dore MP, Bassotti G. The PNEI holistic approach in coloproctology. Tech Coloproctol 2015;19:269-73. [PMID: 25820513 DOI: 10.1007/s10151-015-1277-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Smythies LE, Smythies JR. Microbiota, the immune system, black moods and the brain-melancholia updated. Front Hum Neurosci 2014;8:720. [PMID: 25309394 DOI: 10.3389/fnhum.2014.00720] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
27 Bokic T, Storr M, Schicho R. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology. 2015;96:76-85. [PMID: 26139425 DOI: 10.1159/000435816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
28 Soncini M, Stasi C, Usai Satta P, Milazzo G, Bianco M, Leandro G, Montalbano LM, Muscatiello N, Monica F, Galeazzi F, Bellini M; AIGO. IBS clinical management in Italy: The AIGO survey. Dig Liver Dis 2019;51:782-9. [PMID: 30448159 DOI: 10.1016/j.dld.2018.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
29 Li J, Yuan B, Li G, Lu X, Guo Y, Yang Y, Liang M, Ding J, Zhou Q. Convergent syndromic atrophy of pain and emotional systems in patients with irritable bowel syndrome and depressive symptoms. Neurosci Lett 2020;723:134865. [PMID: 32109554 DOI: 10.1016/j.neulet.2020.134865] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
30 Stasi C, Caserta A, Nisita C, Cortopassi S, Fani B, Salvadori S, Pancetti A, Bertani L, Gambaccini D, de Bortoli N, Dell'Osso L, Blandizzi C, Marchi S, Bellini M. The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment. J Gastroenterol Hepatol 2019;34:713-9. [PMID: 29971822 DOI: 10.1111/jgh.14375] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
31 Riezzo G, Chimienti G, Clemente C, D'Attoma B, Orlando A, Mammone Rinaldi C, Russo F. Colonic Transit Time and Gut Peptides in Adult Patients with Slow and Normal Colonic Transit Constipation. Biomed Res Int 2017;2017:3178263. [PMID: 29082242 DOI: 10.1155/2017/3178263] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Buckley MM, O'Mahony SM, O'Malley D. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2014;20:8846-8858. [PMID: 25083058 DOI: 10.3748/wjg.v20.i27.8846] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
33 Silva AR, Gonçalves-de-Albuquerque CF, Pérez AR, Carvalho VF. Immune-endocrine interactions related to a high risk of infections in chronic metabolic diseases: The role of PPAR gamma. Eur J Pharmacol 2019;854:272-81. [PMID: 30974105 DOI: 10.1016/j.ejphar.2019.04.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
34 Pierce AN, Christianson JA. Stress and Chronic Pelvic Pain. Molecular and Cell Biology of Pain. Elsevier; 2015. pp. 509-35. [DOI: 10.1016/bs.pmbts.2014.11.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
35 Farup PG, Ueland T, Rudi K, Lydersen S, Hestad K. Functional Bowel Disorders Are Associated with a Central Immune Activation. Gastroenterol Res Pract 2017;2017:1642912. [PMID: 29201045 DOI: 10.1155/2017/1642912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Stasi C, Sadalla S, Milani S. The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis. Curr Drug Metab 2019;20:646-55. [PMID: 31345143 DOI: 10.2174/1389200220666190725115503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
37 Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. 2013;6:93-96. [PMID: 23935726 DOI: 10.3892/etm.2013.1101] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
38 Thomas A, Quigley EM. Diet and irritable bowel syndrome: . Current Opinion in Gastroenterology 2015;31:166-71. [DOI: 10.1097/mog.0000000000000158] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Liu G, Li S, Chen N, Zhao Z, Guo M, Liu H, Feng J, Zhang D, Yao Z, Hu B. Inter-hemispheric Functional Connections Are More Vulnerable to Attack Than Structural Connection in Patients With Irritable Bowel Syndrome. J Neurogastroenterol Motil 2021;27:426-35. [PMID: 34210908 DOI: 10.5056/jnm20134] [Reference Citation Analysis]
40 Chira A, Dumitrascu DL. Serum biomarkers for irritable bowel syndrome. Clujul Med 2015;88:258-64. [PMID: 26609254 DOI: 10.15386/cjmed-496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
41 Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol. 2014;20:8807-8820. [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
42 Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials. Gut Pathog. 2013;5:4. [PMID: 23497650 DOI: 10.1186/1757-4749-5-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
43 Koloski N, Holtmann G, Talley NJ. Is there a causal link between psychological disorders and functional gastrointestinal disorders? Expert Rev Gastroenterol Hepatol 2020;14:1047-59. [PMID: 32715790 DOI: 10.1080/17474124.2020.1801414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
44 Li L, Cui H, Li T, Qi J, Chen H, Gao F, Tian X, Mu Y, He R, Lv S, Chu F, Xu B, Wang P, Lei H, Xu H, Wang C. Synergistic Effect of Berberine-Based Chinese Medicine Assembled Nanostructures on Diarrhea-Predominant Irritable Bowel Syndrome In Vivo. Front Pharmacol 2020;11:1210. [PMID: 32982718 DOI: 10.3389/fphar.2020.01210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
45 Nordin S. Mechanisms underlying nontoxic indoor air health problems: A review. International Journal of Hygiene and Environmental Health 2020;226:113489. [DOI: 10.1016/j.ijheh.2020.113489] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
46 Bellini M, Gambaccini D, Usai-Satta P, De Bortoli N, Bertani L, Marchi S, Stasi C. Irritable bowel syndrome and chronic constipation: Fact and fiction. World J Gastroenterol 2015;21:11362-70. [PMID: 26523103 DOI: 10.3748/wjg.v21.i40.11362] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
47 González-Arancibia C, Escobar-Luna J, Barrera-Bugueño C, Díaz-Zepeda C, González-Toro MP, Olavarría-Ramírez L, Zanelli-Massai F, Gotteland M, Bravo JA, Julio-Pieper M. What goes around comes around: novel pharmacological targets in the gut-brain axis. Therap Adv Gastroenterol 2016;9:339-53. [PMID: 27134664 DOI: 10.1177/1756283X16630718] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
48 Vandeleest JJ, Beisner BA, Hannibal DL, Nathman AC, Capitanio JP, Hsieh F, Atwill ER, McCowan B. Decoupling social status and status certainty effects on health in macaques: a network approach. PeerJ 2016;4:e2394. [PMID: 27672495 DOI: 10.7717/peerj.2394] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
49 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
50 Barrett KE, Keely SJ. Electrolyte Secretion and Absorption in the Small Intestine and Colon. In: Podolsky DK, Camilleri M, Fitz JG, Kalloo AN, Shanahan F, Wang TC, editors. Yamada' s Textbook of Gastroenterology. Oxford: John Wiley & Sons, Ltd; 2015. pp. 420-49. [DOI: 10.1002/9781118512074.ch24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Weng Y, Qi R, Liu C, Ke J, Xu Q, Wang F, Zhang LJ, Lu GM. Disrupted functional connectivity density in irritable bowel syndrome patients. Brain Imaging Behav 2017;11:1812-22. [PMID: 27848148 DOI: 10.1007/s11682-016-9653-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
52 Stasi C, Nisita C, Cortopassi S, Corretti G, Gambaccini D, De Bortoli N, Fani B, Simonetti N, Ricchiuti A, Dell'Osso L, Marchi S, Bellini M. Subthreshold Psychiatric Psychopathology in Functional Gastrointestinal Disorders: Can It Be the Bridge between Gastroenterology and Psychiatry? Gastroenterol Res Pract 2017;2017:1953435. [PMID: 29213280 DOI: 10.1155/2017/1953435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
53 Velázquez-Moctezuma J, Domínguez-Salazar E, Gómez-González B. Beyond the borders: the gates and fences of neuroimmune interaction. Front Integr Neurosci 2014;8:26. [PMID: 24659958 DOI: 10.3389/fnint.2014.00026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
54 Umrani S, Jamshed W, Rizwan A. Association Between Psychological Disorders and Irritable Bowel Syndrome. Cureus 2021;13:e14513. [PMID: 34007764 DOI: 10.7759/cureus.14513] [Reference Citation Analysis]
55 Louw A, Schmidt S, Zimney K, Puentedura EJ. Treat the Patient, Not the Label: A Pain Neuroscience Update. Journal of Women's Health Physical Therapy 2019;43:89-97. [DOI: 10.1097/jwh.0000000000000121] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Wall GC, Bryant GA, Bottenberg MM, Maki ED, Miesner AR. Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol. 2014;20:8796-8806. [PMID: 25083054 DOI: 10.3748/wjg.v20.i27.8796] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
57 Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014;49:1193-1205. [PMID: 24845149 DOI: 10.1007/s00535-014-0966-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
58 Scalera A, Di Minno MN, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19:5402-5420. [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
59 Tsigaridas A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, Viazis N, Karamanolis G, Karamanolis DG, Tsangaris GT, Mantzaris GJ, Gazouli M. Proteomics and irritable bowel syndrome. Expert Rev Proteomics 2017;14:461-8. [PMID: 28395553 DOI: 10.1080/14789450.2017.1317600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
60 Sibelli A, Chalder T, Everitt H, Workman P, Windgassen S, Moss-morris R. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med 2016;46:3065-80. [DOI: 10.1017/s0033291716001987] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 13.6] [Reference Citation Analysis]
61 Fukuba N, Ishihara S, Tada Y, Oshima N, Moriyama I, Yuki T, Kawashima K, Kushiyama Y, Fujishiro H, Kinoshita Y. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study. Scand J Gastroenterol. 2014;49:674-680. [PMID: 24646420 DOI: 10.3109/00365521.2014.898084] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
62 Meggs WJ. The Role of Neurogenic Inflammation in Chemical Sensitivity. Ecopsychology 2017;9:83-9. [DOI: 10.1089/eco.2016.0045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA. Functional abdominal pain disorders in children. Expert Review of Gastroenterology & Hepatology 2018;12:369-90. [DOI: 10.1080/17474124.2018.1438188] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]